133 related articles for article (PubMed ID: 31275557)
1. Pan-cancer repository of validated natural and cryptic mRNA splicing mutations.
Shirley BC; Mucaki EJ; Rogan PK
F1000Res; 2018; 7():1908. PubMed ID: 31275557
[TBL] [Abstract][Full Text] [Related]
2. Expression Changes Confirm Genomic Variants Predicted to Result in Allele-Specific, Alternative mRNA Splicing.
Mucaki EJ; Shirley BC; Rogan PK
Front Genet; 2020; 11():109. PubMed ID: 32211018
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive prediction of mRNA splicing effects of BRCA1 and BRCA2 variants.
Mucaki EJ; Ainsworth P; Rogan PK
Hum Mutat; 2011 Jul; 32(7):735-42. PubMed ID: 21523855
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive profiling of cancer neoantigens from aberrant RNA splicing.
Wickland DP; McNinch C; Jessen E; Necela B; Shreeder B; Lin Y; Knutson KL; Asmann YW
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38754917
[TBL] [Abstract][Full Text] [Related]
5. Automated splicing mutation analysis by information theory.
Nalla VK; Rogan PK
Hum Mutat; 2005 Apr; 25(4):334-42. PubMed ID: 15776446
[TBL] [Abstract][Full Text] [Related]
6. Read-Split-Run: an improved bioinformatics pipeline for identification of genome-wide non-canonical spliced regions using RNA-Seq data.
Bai Y; Kinne J; Donham B; Jiang F; Ding L; Hassler JR; Kaufman RJ
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):503. PubMed ID: 27556805
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing and ACMG-AMP-2015-based classification of PALB2 genetic variants: an ENIGMA report.
Lopez-Perolio I; Leman R; Behar R; Lattimore V; Pearson JF; Castéra L; Martins A; Vaur D; Goardon N; Davy G; Garre P; García-Barberán V; Llovet P; Pérez-Segura P; Díaz-Rubio E; Caldés T; Hruska KS; Hsuan V; Wu S; Pesaran T; Karam R; Vallon-Christersson J; Borg A; ; Valenzuela-Palomo A; Velasco EA; Southey M; Vreeswijk MPG; Devilee P; Kvist A; Spurdle AB; Walker LC; Krieger S; de la Hoya M
J Med Genet; 2019 Jul; 56(7):453-460. PubMed ID: 30890586
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in silico analysis reveals an efficient algorithm to predict the splicing consequences of mutations at the 5' splice sites.
Sahashi K; Masuda A; Matsuura T; Shinmi J; Zhang Z; Takeshima Y; Matsuo M; Sobue G; Ohno K
Nucleic Acids Res; 2007; 35(18):5995-6003. PubMed ID: 17726045
[TBL] [Abstract][Full Text] [Related]
9. Interpretation, stratification and evidence for sequence variants affecting mRNA splicing in complete human genome sequences.
Shirley BC; Mucaki EJ; Whitehead T; Costea PI; Akan P; Rogan PK
Genomics Proteomics Bioinformatics; 2013 Apr; 11(2):77-85. PubMed ID: 23499923
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated SF3B1 mutants recognize otherwise inaccessible cryptic 3' splice sites within RNA secondary structures.
Kesarwani AK; Ramirez O; Gupta AK; Yang X; Murthy T; Minella AC; Pillai MM
Oncogene; 2017 Feb; 36(8):1123-1133. PubMed ID: 27524419
[TBL] [Abstract][Full Text] [Related]
11. Familial adenomatous polyposis: aberrant splicing due to missense or silent mutations in the APC gene.
Aretz S; Uhlhaas S; Sun Y; Pagenstecher C; Mangold E; Caspari R; Möslein G; Schulmann K; Propping P; Friedl W
Hum Mutat; 2004 Nov; 24(5):370-80. PubMed ID: 15459959
[TBL] [Abstract][Full Text] [Related]
12. Discover hidden splicing variations by mapping personal transcriptomes to personal genomes.
Stein S; Lu ZX; Bahrami-Samani E; Park JW; Xing Y
Nucleic Acids Res; 2015 Dec; 43(22):10612-22. PubMed ID: 26578562
[TBL] [Abstract][Full Text] [Related]
13. Information analysis of human splice site mutations.
Rogan PK; Faux BM; Schneider TD
Hum Mutat; 1998; 12(3):153-71. PubMed ID: 9711873
[TBL] [Abstract][Full Text] [Related]
14. Cancer-Associated Perturbations in Alternative Pre-messenger RNA Splicing.
Shkreta L; Bell B; Revil T; Venables JP; Prinos P; Elela SA; Chabot B
Cancer Treat Res; 2013; 158():41-94. PubMed ID: 24222354
[TBL] [Abstract][Full Text] [Related]
15. Interpretation of mRNA splicing mutations in genetic disease: review of the literature and guidelines for information-theoretical analysis.
Caminsky N; Mucaki EJ; Rogan PK
F1000Res; 2014; 3():282. PubMed ID: 25717368
[TBL] [Abstract][Full Text] [Related]
16. Splicing mutation analysis reveals previously unrecognized pathways in lymph node-invasive breast cancer.
Dorman SN; Viner C; Rogan PK
Sci Rep; 2014 Nov; 4():7063. PubMed ID: 25394353
[TBL] [Abstract][Full Text] [Related]
17. The effect of disease-associated HRPT2 mutations on splicing.
Hahn MA; McDonnell J; Marsh DJ
J Endocrinol; 2009 Jun; 201(3):387-96. PubMed ID: 19332451
[TBL] [Abstract][Full Text] [Related]
18. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.
Wimmer K; Roca X; Beiglböck H; Callens T; Etzler J; Rao AR; Krainer AR; Fonatsch C; Messiaen L
Hum Mutat; 2007 Jun; 28(6):599-612. PubMed ID: 17311297
[TBL] [Abstract][Full Text] [Related]
19. EuSplice: a unified resource for the analysis of splice signals and alternative splicing in eukaryotic genes.
Bhasi A; Pandey RV; Utharasamy SP; Senapathy P
Bioinformatics; 2007 Jul; 23(14):1815-23. PubMed ID: 17344236
[TBL] [Abstract][Full Text] [Related]
20. TassDB2 - A comprehensive database of subtle alternative splicing events.
Sinha R; Lenser T; Jahn N; Gausmann U; Friedel S; Szafranski K; Huse K; Rosenstiel P; Hampe J; Schuster S; Hiller M; Backofen R; Platzer M
BMC Bioinformatics; 2010 Apr; 11():216. PubMed ID: 20429909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
